Metraipolis › archive › dc_fd7a8220ee3d

Real-world impact of mepolizumab on pediatric and adolescent patients with severe asthma — Europe PMC PMID:41660046

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41660046
DOI
10.1016/j.jacig.2025.100638
License (as archived)
solo-consultazione
Archived
2026-11-07T12:07:51.144Z
SHA-256 of the archived text
8b80065689aeff628b94d2bf3da3a35a079f15fc1b206ede040245f7aadc92b0
Stable URL of this page
https://metraipolis.com/documento/dc_fd7a8220ee3d

How to cite

Real-world impact of mepolizumab on pediatric and adolescent patients with severe asthma — Europe PMC PMID:41660046 — Europe PMC (en), https://europepmc.org/article/MED/41660046 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fd7a8220ee3d (Metraipolis archive dc_fd7a8220ee3d, sha256 8b80065689aeff628b94d2bf3da3a35a079f15fc1b206ede040245f7aadc92b0)
BibTeX
@misc{dcfd7a8220ee3d,
  title = {Real-world impact of mepolizumab on pediatric and adolescent patients with severe asthma — Europe PMC PMID:41660046},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41660046},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fd7a8220ee3d; sha256 8b80065689aeff628b94d2bf3da3a35a079f15fc1b206ede040245f7aadc92b0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41660046. Agents can read the archived copy with the MCP tool read_document.